These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 11010748

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 5. Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):85-7. PubMed ID: 11010750
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention.
    Prescrire Int; 2000 Jun; 9(47):89-90. PubMed ID: 11010752
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
    Beinart SC, Kolm P, Veledar E, Zhang Z, Mahoney EM, Bouin O, Gabriel S, Jackson J, Chen R, Caro J, Steinhubl S, Topol E, Weintraub WS.
    J Am Coll Cardiol; 2005 Sep 06; 46(5):761-9. PubMed ID: 16139122
    [Abstract] [Full Text] [Related]

  • 14. Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.
    Ray JG, Hamielec CM.
    Can J Cardiol; 2004 Jun 06; 20(8):829-30. PubMed ID: 15229768
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antiplatelet therapies for secondary stroke prevention: an update on clinical and cost-effectiveness.
    Rothlisberger JM, Ovbiagele B.
    J Comp Eff Res; 2015 Aug 06; 4(4):377-84. PubMed ID: 26274799
    [Abstract] [Full Text] [Related]

  • 17. Aggrenox: a combination of antiplatelet drugs for stroke prevention.
    Med Lett Drugs Ther; 2000 Feb 07; 42(1071):11-2. PubMed ID: 10725967
    [No Abstract] [Full Text] [Related]

  • 18. Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty.
    Matchar DB, Samsa GP, Liu S.
    Value Health; 2005 Feb 07; 8(5):572-80. PubMed ID: 16176495
    [Abstract] [Full Text] [Related]

  • 19. Clopidogrel: new preparation. An alternative to aspirin.
    Prescrire Int; 1999 Dec 07; 8(44):163-4. PubMed ID: 11503810
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.